SCHEMBL7207266

SCHEMBL7207266

COc1ccc2c(c1)/C(=C/CCN1CCC(O)CC1)c1cccnc1CO2

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 2/20 0.49
CHRM2 P08172 1/20 0.49
CCR5 P51681 1/20 0.49
TBXA2R P21731 4/20 0.39
MAOB P27338 1/20 0.38
HRH1 P35367 5/20 0.38
ADRA1D P25100 1/20 0.37
ADRA1A P35348 1/20 0.37
ADRA1B P35368 1/20 0.37
SIGMAR1 Q99720 3/20 0.36
KDM4E B2RXH2 1/20 0.36
NPC1 O15118 1/20 0.36
ALDH1A1 P00352 1/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
HPGD P15428 1/20 0.36
ALOX12 P18054 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
TDP1 Q9NUW8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7207268 1.00 CCR1 (0.49) CCR1CHRM2CCR5TBXA2RMAOB
SCHEMBL7211997 0.89 CCR1 (0.47) CCR1CHRM2CCR5TBXA2RHRH1
SCHEMBL7212000 0.89 CCR1 (0.47) CCR1CHRM2CCR5TBXA2RHRH1
SCHEMBL14420183 0.88 CCR1 (0.47) CCR1CHRM2CCR5TBXA2RHRH1
SCHEMBL7210838 0.88 HRH3 (0.46) CCR1CHRM2CCR5TBXA2RMAOB
SCHEMBL7210843 0.88 HRH3 (0.46) CCR1CHRM2CCR5TBXA2RMAOB
SCHEMBL13824388 0.88 CCR1 (0.46) CCR1CHRM2CCR5TBXA2RHRH1
SCHEMBL10287855 0.88 CCR1 (0.46) CCR1CHRM2CCR5TBXA2RHRH1
SCHEMBL7212913 0.87 CCR1 (0.54) CCR1CHRM2CCR5KDM4E
SCHEMBL7212910 0.87 CCR1 (0.54) CCR1CHRM2CCR5KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9663537-B2 Chemokine receptor antagonists and methods of use MILLENNIUM PHARMACEUTICALS, INC. (US) 2017-05-30 US disclosed
US-6613905-B1 Treating or preventing a disease associated with aberrant leukocyte recruitment and/or activation MILLENNIUM PHARMACEUTICALS, INC. 2003-09-02 US disclosed